Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy

Diabetes ◽

10.2337/diabetes.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Clinical and Neurophysiological Studies of Aldose Reductase Inhibitor Ponalrestat in Chronic Symptomatic Diabetic Peripheral Neuropathy

Diabetes ◽

10.2337/diab.40.1.129 ◽

1991 ◽

Vol 40 (1) ◽

pp. 129-133 ◽

Author(s):

C. M. Florkowski ◽

B. R. Rowe ◽

S. Nightingale ◽

T. C. Harvey ◽

A. H. Barnett

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Diabetes Care ◽

10.2337/dc05-2370 ◽

2006 ◽

Vol 29 (7) ◽

pp. 1538-1544 ◽

Author(s):

N. Hotta ◽

Y. Akanuma ◽

R. Kawamori ◽

K. Matsuoka ◽

Y. Oka ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Diabetes Complications ◽

Aldose Reductase Inhibitor ◽

Clinical Effects

Download Full-text

Effect of an Aldose Reductase Inhibitor on Diabetic Peripheral Neuropathy

Archives of Neurology ◽

10.1001/archneur.1981.00510020091017 ◽

1981 ◽

Vol 38 (2) ◽

pp. 133 ◽

Author(s):

Antonio Culebras

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat

Diabetic Medicine ◽

10.1111/j.1464-5491.2008.02490.x ◽

2008 ◽

Vol 25 (7) ◽

pp. 818-825 ◽

Author(s):

N Hotta ◽

R. Kawamori ◽

Y. Atsumi ◽

M. Baba ◽

H. Kishikawa ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Diabetic Peripheral Neuropathy: Effect of An Aldose Reductase Inhibitor

Clinical Science ◽

10.1042/cs065019pb ◽

1983 ◽

Vol 65 (3) ◽

pp. 19P-20P

Author(s):

I.G. Lewin ◽

I.A.D. O'Brien ◽

M.H. Morgan ◽

R.J.M. Corrall

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor

Download Full-text

Long-term treatment of subclinical diabetic peripheral neuropathy with aldose reductase inhibitor

Electroencephalography and Clinical Neurophysiology ◽

10.1016/0013-4694(93)90956-v ◽

1993 ◽

Vol 87 (2) ◽

pp. S29

Author(s):

F.P. Serra ◽

C. Canale ◽

G. Nolfe ◽

V. Palma ◽

F. Rotondi ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Aldose Reductase Inhibitor ◽

Long Term Treatment

Download Full-text

Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor

The American Journal of Medicine ◽

10.1016/0002-9343(85)90505-4 ◽

1985 ◽

Vol 79 (5) ◽

pp. 13-17 ◽

Author(s):

Douglas A. Greene ◽

Sarah A. Lattimer

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Recent Advances

Download Full-text

Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study

Diabetes Care ◽

10.2337/diacare.24.10.1776 ◽

2001 ◽

Vol 24 (10) ◽

pp. 1776-1782 ◽

Author(s):

N. Hotta ◽

T. Toyota ◽

K. Matsuoka ◽

Y. Shigeta ◽

R. Kikkawa ◽

...

Keyword(s):

Peripheral Neuropathy ◽

Aldose Reductase ◽

Clinical Efficacy ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of Nɛ-carboxymethyl lysine

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2008.10.005 ◽

2010 ◽

Vol 24 (6) ◽

pp. 424-432 ◽

Author(s):

Toshihide Kawai ◽

Izumi Takei ◽

Mikiya Tokui ◽

Osamu Funae ◽

Kazunori Miyamoto ◽

...

Keyword(s):

Type 2 Diabetes ◽

Peripheral Neuropathy ◽

Aldose Reductase ◽

Diabetic Peripheral Neuropathy ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Carboxymethyl Lysine

Download Full-text

Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy

Diabetologia ◽

10.1007/bf00262218 ◽

1984 ◽

Vol 26 (6) ◽

Author(s):

I.G. Lewin ◽

I.A.D. O'Brien ◽

M.H. Morgan ◽

R.J.M. Corrall

Keyword(s):

Diabetic Neuropathy ◽

Aldose Reductase ◽

Reductase Inhibitor ◽

Aldose Reductase Inhibitor ◽

Neurophysiological Studies

Download Full-text